Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShield Thera Share News (STX)

Share Price Information for Shield Thera (STX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.35
Bid: 1.30
Ask: 1.40
Change: 0.00 (0.00%)
Spread: 0.10 (7.692%)
Open: 1.35
High: 1.375
Low: 1.35
Prev. Close: 1.35
STX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK EXECUTIVE CHANGE SUMMARY: New Chairs For Matomy And Shield

Tue, 26th May 2020 14:22

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Tuesday and not separately reported by Alliance News:

----------

Matomy Media Group Ltd - media technology - Appoints Amitay Weiss as chair. Says Chief Financial Officer Ilan Tamir to be interim CEO as well as CFO before leaving the company on September 30. The Tel Aviv-based company's brief announcement didn't provide any further details about the two management changes. Back in February, Matomy said Sami Totah, chair since June 2018, had resigned following the sale of the 9.5% stake in Matomy held by Viola AV Adsmarket LP, where Totah is general partner. In March, as Matomy reported a widened loss for 2019, CFO Tamir said: "We are glad to have brought Matomy to safe harbours. We were successful in selling Team Internet, which enabled us to redeem the bond, and pay off all of the company's debts." In December of last year, Matomy agreed to sell its 90% stake in Team Internet, which provides services in the direct navigation search market, to CentralNic Group PLC.

----------

Shield Therapeutics PLC - iron deficiency treatments - Hans Peter Hasler to become non-executive chair from annual general meeting on June 18, replacing James Karis. Hasler joined the Shield Therapeutics board in July 2018. He was COO of Elan Corp and of Biogen Inc.

----------

SQN Secured Income Fund PLC - secured lending income investment - Chair Ken Hillen steps down as a director, citing a potential conflict between his business interests and those of the investment trust in the near term. Hillen was named chair at the end of 2018. David Stevenson steps up to chair from Tuesday. Stevenson has been a director since 2015.

----------

Bank of Cyprus Holdings PLC - universal banking - Takis Arapoglou re-elected as chair. Lyn Grobler is elected vice-chair, succeeding Maksim Goldman.

----------

PureTech Health PLC - clinical-stage biotherapeutics - Vor Biopharma, a company founded by PureTech Health, names Nathan Jorgensen as chief financial officer. Jorgensen has worked in healthcare-focused finance roles at Qatar Investment Authority and Stifel Nicolaus.

----------

Dev Clever Holdings PLC - cloud-based gamification and virtual reality - Adds Chief Operating Officer Tim Heaton to board, with immediate effect. Heaton joined Dev Clever back in October, having been business development director for Europe, Middle East and Africa at Oracle Corp. Heaton has been leading Dev Clever's efforts to integrate its educational careers guidance software applications with a hardware manufacturer. This recently resulted in a three-year exclusive contract with China's Lenovo Group Ltd.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
1 May 2020 13:28

UK TRADING UPDATE SUMMARY: Avacta, Genedrive Progress With Virus Tests

UK TRADING UPDATE SUMMARY: Avacta, Genedrive Progress With Virus Tests

Read more
1 May 2020 09:55

Shield Therapeutics FY revenues impacted by milestone repayment

(Sharecast News) - Pharmaceuticals outfit Shield Therapeutics warned on Friday that full-year revenues would be lower than originally anticipated after it had to repay a sizeable milestone payment.

Read more
22 Apr 2020 15:13

UK EXECUTIVE CHANGE SUMMARY: Shield Therapeutics Replaces Founder

UK EXECUTIVE CHANGE SUMMARY: Shield Therapeutics Replaces Founder

Read more
18 Mar 2020 07:33

Shield Therapeutics Starts Independent Review Into Feraccru Study

Shield Therapeutics Starts Independent Review Into Feraccru Study

Read more
17 Mar 2020 15:17

Shield launches review after spotting flaw in 'Feraccru' study

(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics updated the market on the 'AEGIS-H2H' clinical trial on Tuesday, the data of which was primarily designed to be used in health economic analyses, pricing and reimbursement applications, as well as marketing purposes.

Read more
27 Jan 2020 15:07

Shield Therapeutics 2019 Revenue To Drop But Will Meet Expectations

Shield Therapeutics 2019 Revenue To Drop But Will Meet Expectations

Read more
27 Jan 2020 08:09

Shield Therapeutics details year of 'material progress'

(Sharecast News) - Drugs developer Shield Therapeutics told investors on Monday that 2019 had been a year of "material progress", with a key success being the recent Federal Drug Administration approval of its iron deficiency treatment, Feraccru/Accrufer.

Read more
8 Jan 2020 09:45

Shield Therapeutics Gets China Licence Agreement For Feraccru/Accrufer

Shield Therapeutics Gets China Licence Agreement For Feraccru/Accrufer

Read more
15 Aug 2019 14:28

DIRECTOR DEALINGS: Shield Therapeutics Chair Buys GBP134,000 In Shares

(Alliance News) - Shield Therapeutics PLC on Thursday said Chair James Karis acquired shares in the pharmaceutical company following a transaction on Tuesday.Karis purchased 75,000 shares a

Read more
7 Aug 2019 12:02

Shield Therapeutics Narrows Interim Losses Amid Expenses Fall

(Alliance News) - Drugmaker Shield Therapeutics said on Wednesday a payment from a commercial partner contributed to a sharp revenue rise in the first half of the year.In the six months to

Read more
3 Jun 2019 10:27

Teva Appeals Shield Therapeutics European Drug Patent Win

LONDON (Alliance News) - Shield Therapeutics PLC on Monday said Israeli pharmaceutical company Teva Pharmaceutical Industries Ltd has filed a notice of appeal on a decision regarding a Shield in a

Read more
26 Apr 2019 18:19

DIRECTOR DEALINGS: Shield Therapeutics Medical Chief Buys Shares

LONDON (Alliance News) - Shield Therapeutics PLC said on Friday that Chief Medical Officer Mark Sampson and his wife Julia have purchased shares in the company on Thursday.Mark bought at a

Read more
24 Apr 2019 12:22

Shield Therapeutics' Feraccru Granted Use Extension In Switzerland

LONDON (Alliance News) - Shield Therapeutics PLC said on Wednesday said the Swiss Agency for Therapeutic Products has approved the Feraccru product to treat iron deficiency in adults with or is to

Read more
17 Apr 2019 18:11

DIRECTOR DEALINGS: Shield Therapeutics Chair Buys GBP40,000 In Shares

LONDON (Alliance News) - Shield Therapeutics PLC said Wednesday Chair James Karis bought 50,000 shares in the company.Karis acquired 46,000 shares at GBP0.815 on Monday, then acquired a at

Read more
17 Apr 2019 18:11

DIRECTOR DEALINGS: Shield Therapeutics Chair Buys GBP40,000 In Shares

LONDON (Alliance News) - Shield Therapeutics PLC said Wednesday Chair James Karis bought 50,000 shares in the company.Karis acquired 46,000 shares at GBP0.815 on Monday, then acquired a at

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.